FDA Committee Recommends COVID-19 Vaccine for Children 5-11 Years Old
COVID-19 vaccines are already authorized for children ages 12 and older, and the shots now have the support of a U.S. Food and Drug Administration (FDA) expert panel for younger children ages 5 to 11. In a 17 to 0 vote, with one abstention, the committee recommended the COVID-19 vaccine made by Pfizer-BioNTech for the youngest group yet to potentially get immunized against the disease in the US. The committee recommended a two-dose regimen at one-third the dosage approved for adults. The FDA now takes the committee’s advice into consideration before making a final recommendation. If the agency decides to recommend th...
Source: TIME: Health - October 26, 2021 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 Source Type: news

Nasal steroid sprays could be effective at preventing serious cases of COVID, study finds
Patients who use nasal steroid sprays for allergies or asthma may be at a lower risk for COVID-19 hospitalization, ICU care, and death, a recent Cleveland Clinic study finds. (Source: the Mail online | Health)
Source: the Mail online | Health - October 26, 2021 Category: Consumer Health News Source Type: news

COVID-19 vaccines safe for people with history of severe allergies, study finds
People with a history of severe allergic reactions to drugs and vaccines can receive both doses of the two-shot COVID-19 inoculations safely, a study published Tuesday by JAMA Network Open found. (Source: Health News - UPI.com)
Source: Health News - UPI.com - October 26, 2021 Category: Consumer Health News Source Type: news

COVID-19 - guidance for management of children admitted to hospital, RCPCH (updated 22nd October 2021)
This best practice advice is focused on the management of confirmed or suspected SARS-CoV-2 infection in children admitted to hospital. This has been produced with the British Paediatric Allergy, Immunity and Infection Group. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - October 26, 2021 Category: Consumer Health News Source Type: news

New Analyses Suggest Favorable Results for STELARA ® (ustekinumab) When Used as a First-Line Therapy for Bio-Naïve Patients with Moderately to Severely Active Crohn’s Disease and Ulcerative Colitis
SPRING HOUSE, PENNSYLVANIA, October 25, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced data from two new analyses of STELARA® (ustekinumab) for the treatment of adults with moderately to severely active Crohn’s disease (CD) and ulcerative colitis (UC).1,2 In a modelled analysisa focused on treatment sequencing using data from randomized controlled trials, network meta-analysis and literature, results showed patient time spent in clinical remission or response was highest when STELARA was used as a first-line advanced therapy for bio-naïve patients with moderately t...
Source: Johnson and Johnson - October 25, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

How Can I Help My Child With a Peanut Allergy?
Title: How Can I Help My Child With a Peanut Allergy?Category: Diseases and ConditionsCreated: 10/25/2021 12:00:00 AMLast Editorial Review: 10/25/2021 12:00:00 AM (Source: MedicineNet Allergies General)
Source: MedicineNet Allergies General - October 25, 2021 Category: Allergy & Immunology Source Type: news

San Diego scientists work on a vaccine against all coronaviruses. Yes, all of them
Scientists at La Jolla Institute for Immunology received $2.6 million as part of a larger effort to develop protective shots against past, present and future coronaviruses. (Source: L.A. Times - Health)
Source: L.A. Times - Health - October 24, 2021 Category: Consumer Health News Authors: Jonathan Wosen Source Type: news

Fatal anaphylaxis due to peanut exposure from oral intercourse - McKibbin LR, Siu SKH, Roberts HT, Shkrum M, Jeimy S.
BACKGROUND: Intimacy-related allergic reactions, including anaphylaxis, are under-reported due to social stigma, lack of awareness, and misdiagnosis. The differential diagnosis for intimacy-related anaphylaxis is extensive and includes systemic human semin... (Source: SafetyLit)
Source: SafetyLit - October 23, 2021 Category: International Medicine & Public Health Tags: Poisoning Source Type: news

Canadians who had allergic reaction to first vaccine dose can safely get second, advisory committee says
Those who had an allergic reaction to their first shot of an mRNA COVID-19 vaccine can safely receive future doses of the same product or a different mRNA vaccine, says Canada's vaccine advisory committee. (Source: CBC | Health)
Source: CBC | Health - October 22, 2021 Category: Consumer Health News Tags: News/Politics Source Type: news

Ibuprofen side effects: Telltale signs on your skin of a ‘serious allergic reaction’
IBUPROFEN is a popular painkiller used for a variety of pain and even inflammation. This medicine available in most pharmacies and supermarkets comes as tablets, capsules and syrup. Like all medicine, ibuprofen has a list of possible side effects. This includes signs on skin signalling an allergic reaction. (Source: Daily Express - Health)
Source: Daily Express - Health - October 22, 2021 Category: Consumer Health News Source Type: news

U.S. CDC Advisory Committee Unanimously Recommends Johnson & Johnson COVID-19 Vaccine as a Booster for All Eligible Individuals Who Receive Authorized COVID-19 Vaccines
NEW BRUNSWICK, N.J., October 21, 2021 – Johnson & Johnson (the Company) today announced that the U.S. Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP), has recommended its COVID-19 vaccine as a booster for all eligible individuals who receive an authorized COVID-19 vaccine. “Today’s recommendation supports the use of the Johnson & Johnson COVID-19 vaccine as a booster for eligible individuals in the U.S. regardless of which vaccine they initially receive,” said Paul Stoffels, M.D., Vice Chairman of the Executive Committee and Chief Scientif...
Source: Johnson and Johnson - October 21, 2021 Category: Pharmaceuticals Source Type: news

CDC Authorizes Boosters of Moderna and Johnson & Johnson COVID-19 Vaccines
Dr. Rochelle Walensky, director of the Centers for Disease Control and Prevention (CDC), authorized booster doses of COVID-19 vaccines for certain groups. Walensky followed the advice of a CDC expert panel, which recommended the boosters in in two unanimous votes earlier in the day. The 15-member Advisory Committee on Immunization Practices (ACIP) advised that anyone who was initially vaccinated with the Moderna shot get a booster at least six months later, and that J&J-Janssen recipients receive a booster at least two months after their initial vaccination. The endorsement follows a similar decision from the Food and ...
Source: TIME: Health - October 21, 2021 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 Source Type: news

CDC Authorizes Boosters of Moderna and Johnson & Johnson COVID-19 Vaccines
Dr. Rochelle Walensky, director of the Centers for Disease Control and Prevention (CDC), authorized booster doses of COVID-19 vaccines for certain groups. Walensky followed the advice of a CDC expert panel, which recommended the boosters in in two unanimous votes earlier in the day. The 15-member Advisory Committee on Immunization Practices (ACIP) advised that anyone who was initially vaccinated with the Moderna shot get a booster at least six months later, and that J&J-Janssen recipients receive a booster at least two months after their initial vaccination. The endorsement follows a similar decision from the Food and ...
Source: TIME: Health - October 21, 2021 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 Source Type: news

Johnson & Johnson COVID-19 Vaccine Booster Shot Authorized for Emergency Use by U.S. FDA
NEW BRUNSWICK, N.J., October 20, 2021 – Johnson & Johnson (NYSE: JNJ) (the Company) today announced the U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) for a booster dose of the Johnson & Johnson COVID-19 vaccine for adults aged 18 and older at least two months following primary vaccination with single-shot Johnson & Johnson COVID-19 vaccine; and for eligible individuals who received a different authorized or approved COVID-19 vaccine. The Johnson & Johnson booster shot will be the same formulation and dosage as the primary shot. The EUA follows a unanimous recomme...
Source: Johnson and Johnson - October 20, 2021 Category: Pharmaceuticals Tags: Latest News Source Type: news

What Happens if You Get Bitten by a Centipede?
Title: What Happens if You Get Bitten by a Centipede?Category: Diseases and ConditionsCreated: 10/20/2021 12:00:00 AMLast Editorial Review: 10/20/2021 12:00:00 AM (Source: MedicineNet Allergies General)
Source: MedicineNet Allergies General - October 20, 2021 Category: Allergy & Immunology Source Type: news

New information standard notice (ISN) published for medicine data transfer
New standards have been issued for IT systems that provide electronic transfer of patient medication and allergy/intolerance data. (Source: NHS Networks)
Source: NHS Networks - October 20, 2021 Category: UK Health Source Type: news

Without Covid-19 jab, ‘reinfection may occur every 16 months’
Reports grow of repeat infection as experts warn prevalence among school pupils puts older people at riskCoronavirus – latest updatesSee all our coronavirus coverageAs Covid-19 infections surge in England, people are increasingly reporting catching Sars-CoV-2 for a second or even third time.New analysis has suggested that unvaccinated individuals should expect to be reinfected with Covid-19 every 16 months, on average.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - October 19, 2021 Category: Science Authors: Linda Geddes Tags: Coronavirus Vaccines and immunisation Immunology Infectious diseases Medical research NHS Science UK news Source Type: news

The Immune System Is an Early Riser, Research Shows The Immune System Is an Early Riser, Research Shows
The migration of dendritic cells to the lymphatic system oscillates according to the time of day, suggesting certain times are associated with higher immune system activity.Quick Take (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 19, 2021 Category: Consumer Health News Tags: Allergy & Clinical Immunology News Source Type: news

Fatal food anaphylaxis: distinguishing fact from fiction - Anagnostou A, Sharma V, Herbert L, Turner PJ.
Although there is a general perception that the prevalence of food allergy is increasing, data supporting this are limited. Food is the least common cause of fatal anaphylaxis, and fortunately, is a very rare event; however, it is also unpredictable. There... (Source: SafetyLit)
Source: SafetyLit - October 19, 2021 Category: International Medicine & Public Health Tags: Home and Consumer Product Safety Source Type: news

Adrenal Sampling in Hyperaldosteronism With Contrast Allergy Adrenal Sampling in Hyperaldosteronism With Contrast Allergy
A patient with primary hyperaldosteronism and a severe allergy to contrast media was able to successfully undergo adrenal vein sampling using dexamethasone as premedication.Journal of the Endocrine Society (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 19, 2021 Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news

Inbox Time Linked to Reduced Odds of Physician Turnover
And increase in mean total messages received per day seen for physicians during March 2020 to June 2021 (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - October 19, 2021 Category: Respiratory Medicine Tags: Cardiology, Dermatology, Endocrinology, Family Medicine, Geriatrics, Gastroenterology, Gynecology, Infections, AIDS, Internal Medicine, Allergy, Nephrology, Neurology, Oncology, Ophthalmology, Orthopedics, ENT, Pediatrics, Psychiatry, Pulmonology, Rheumat Source Type: news

Dr MARTIN SCURR answers your health questions 
DR MARTIN SCURR: This is almost certainly chronic rhinosinusitis, where the lining of the nose and sinuses become infected or inflamed by allergy. (Source: the Mail online | Health)
Source: the Mail online | Health - October 19, 2021 Category: Consumer Health News Source Type: news

Biologic Therapies Available for Pediatric Patients With Asthma
Pediatricians should refer patients to a pediatric subspecialist to identify candidates for biologic therapy and select the appropriate medication (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - October 18, 2021 Category: Respiratory Medicine Tags: Dermatology, Family Medicine, Internal Medicine, Allergy, Pediatrics, Pharmacy, Pulmonology, Journal, Source Type: news

Vaccine allergy? Experts say most past reactions not valid reason for exemptions
Allergists across the country have safely inoculated most patients who come into their clinics, regardless of allergy history, says an Ontario doctor who's noticed an uptick in requests for allergy assessments after the government began implementing COVID-19 vaccine certificates last month. (Source: CBC | Health)
Source: CBC | Health - October 17, 2021 Category: Consumer Health News Tags: News/Canada/Hamilton Source Type: news

Where's the line on who gets COVID booster shots?
Many Canadians are wondering why more people are eligible for booster shots in countries like the U.S. and Israel. Immunologists and infectious disease experts say the guidelines in Canada make scientific sense. (Source: CBC | Health)
Source: CBC | Health - October 16, 2021 Category: Consumer Health News Tags: News/Health Source Type: news

Why doctors say COVID booster shots aren't for everyone — yet
Many Canadians are wondering why more people are eligible for booster shots in countries like the U.S. and Israel. Immunologists and infectious disease experts say the guidelines in Canada make scientific sense. (Source: CBC | Health)
Source: CBC | Health - October 16, 2021 Category: Consumer Health News Tags: News/Health Source Type: news

A decade after gene therapy, children born with deadly immune disorder remain healthy
Over a decade ago, UCLA physician-scientists began using a pioneering gene therapy they developed to treat children born with a rare and deadly immune system disorder.They now report that the effects of the therapy appear to be long-lasting, with 90% of patients who received the treatment eight to 11 years ago still disease-free.ADA-SCID, oradenosine deaminase –deficient severe combined immunodeficiency, is caused by mutations in the gene that creates the ADA enzyme, which is essential to a functioning immune system. For babies with the disease, exposure to everyday germs can be fatal, and if untreated, most will die...
Source: UCLA Newsroom: Health Sciences - October 15, 2021 Category: Universities & Medical Training Source Type: news

The FDA ’s Vaccine Expert Panel Recommends Approval of a J & J Booster for Anyone Who Had an Initial Shot
The Food and Drug Administration’s (FDA) expert vaccine panel on Friday, Oct. 15, recommended a booster dose of the Johnson&Johnson-Janssen COVID-19 vaccine. In a unanimous vote, the 19-member panel recommended the booster for anyone who was previously immunized with the vaccine, at least two months after the that first dose. With the advice, the panel has now backed boosters for all three vaccines currently available in the US. J&J’s vaccine is the only one authorized in the U.S. (and globally) that requires only a single dose. If the FDA accepts the committee’s decision, which it is expected to ...
Source: TIME: Health - October 15, 2021 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 healthscienceclimate Source Type: news

Johnson & Johnson COVID-19 Vaccine Booster Shot Unanimously Recommended for Emergency Use Authorization by U.S. FDA Advisory Committee
NEW BRUNSWICK, N.J., October 15, 2021 – Johnson & Johnson (NYSE: JNJ) (the Company) today announced the U.S. Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC) unanimously voted 19-0 to recommend Emergency Use Authorization (EUA) for a booster dose of the Johnson & Johnson COVID-19 vaccine for adults aged 18 and older at least two months following initial vaccination with the single-shot vaccine. The vote was based on findings from two Company clinical trials, including the Phase 3 ENSEMBLE 2 study, which evaluated a booster dose of the Johnson &...
Source: Johnson and Johnson - October 15, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Vacancy: Editor-in-Chief of the Journal of Nutritional Science (JNS)
The Trustees are seeking applications  for an Editor-in-Chief of the Journal of Nutritional Science (JNS). JNS is an international, peer-reviewed, online only, open access journal that welcomes high-quality research articles in all aspects of nutrition. The underlying aim of all work should be, as far as possible, to develop nutritional concepts - though the key criterion for acceptance is scientific soundness.  JNS encompasses the full spectrum of nutritional science including public health nutrition, epidemiology, dietary surveys, nutritional requirements, metabolic studies, body composition, energet...
Source: The Nutrition Society - October 15, 2021 Category: Nutrition Authors: Cassandra Ellis Source Type: news

OPSYNVI ® (macitentan and tadalafil) Becomes the First and Only Health Canada-Approved Once Daily Fixed Dose Combination Treatment for Patients with Pulmonary Arterial Hypertension (PAH)
Toronto, ON, (October 15, 2021) – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that Health Canada approved OPSYNVI® (macitentan 10mg and tadalafil 40mg) for the long-term treatment of pulmonary arterial hypertension (PAH, World Health Organization [WHO] Group 1) to reduce morbidity in patients of WHO functional class (FC) II or III whose PAH is idiopathic, heritable, or associated with connective tissue disease or congenital heart disease.OPSYNVI® should be used in patients who are currently treated concomitantly with stable doses of macitentan 10mg and tadalafil 40mg (20mg x ...
Source: Johnson and Johnson - October 15, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Janssen Showcases Commitment to Advancing Scientific Innovation in Pulmonary Arterial Hypertension (PAH) at CHEST 2021 Annual Meeting
TITUSVILLE, N.J. – October 14, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today 11* abstracts highlighting data from its pulmonary hypertension (PH) portfolio will be presented at CHEST 2021, the annual meeting of the American College of Chest Physicians, held virtually October 17-20.Data presentations from eight abstracts will provide additional evidence supporting the role of objective multiparameter risk assessment approaches in helping to optimize treatment and care for pulmonary arterial hypertension (PAH), as well as the impact of earlier and comprehensive therapy with ...
Source: Johnson and Johnson - October 14, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Immunic, Inc. Appoints Patrick Walsh as Chief Business Officer
NEW YORK, Oct. 14, 2021 -- (Healthcare Sales & Marketing Network) -- Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies focused on treating chronic inflammatory and autoimm... Biopharmaceuticals, Personnel Immunic , immune modulator (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 14, 2021 Category: Pharmaceuticals Source Type: news

IgE Ratios May Provide More Accurate Allergy Diagnosis IgE Ratios May Provide More Accurate Allergy Diagnosis
A ratio approach involving total IgE, serum-specific IgE, and allergen components is interesting but may not be practical, especially in the United States.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 14, 2021 Category: Consumer Health News Tags: Allergy & Clinical Immunology News Source Type: news

No Connection Between Allergic Diseases and Mental Disorders No Connection Between Allergic Diseases and Mental Disorders
Study may settle a long-simmering question arising from high rates of comorbidity.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 13, 2021 Category: Consumer Health News Tags: Allergy & Clinical Immunology News Source Type: news

Data up to 8-years for Roche ’s OCREVUS (ocrelizumab) show early and ongoing treatment significantly reduced risk of requiring a walking aid in relapsing multiple sclerosis and disability progression in primary progressive multiple sclerosis
Basel, 13 October 2021 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced new long-term data that reinforce the benefit of early initiation and ongoing treatment of OCREVUS® (ocrelizumab) on disability progression in relapsing multiple sclerosis (RMS) and primary progressive MS (PPMS), as well as safety outcomes for an analysis of shorter 2-hour infusion in minority populations. OCREVUS data from all clinical trials consistently show a favourable benefit-risk profile over eight years. Roche and research partners will also present four late-breaking abstracts to share the latest data regarding COVID-19 and vacci...
Source: Roche Media News - October 13, 2021 Category: Pharmaceuticals Source Type: news

Data up to 8-years for Roche ’s OCREVUS (ocrelizumab) show early and ongoing treatment significantly reduced risk of requiring a walking aid in relapsing multiple sclerosis and disability progression in primary progressive multiple sclerosis
Basel, 13 October 2021 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced new long-term data that reinforce the benefit of early initiation and ongoing treatment of OCREVUS® (ocrelizumab) on disability progression in relapsing multiple sclerosis (RMS) and primary progressive MS (PPMS), as well as safety outcomes for an analysis of shorter 2-hour infusion in minority populations. OCREVUS data from all clinical trials consistently show a favourable benefit-risk profile over eight years. Roche and research partners will also present four late-breaking abstracts to share the latest data regarding COVID-19 and vacci...
Source: Roche Investor Update - October 13, 2021 Category: Pharmaceuticals Source Type: news

Mennonite Infants May Be Better Protected Against Allergies Mennonite Infants May Be Better Protected Against Allergies
The breast milk of mothers in a Mennonite community was shown to have higher concentrations of antibodies, suggesting that these children may acquire better protection against allergic diseases.Medscape Medical News (Source: Medscape Pediatrics Headlines)
Source: Medscape Pediatrics Headlines - October 12, 2021 Category: Pediatrics Tags: Allergy & Clinical Immunology News Source Type: news

Scientists discover a highly potent antibody against SARS-CoV-2
The newly identified antibody was isolated using lymphocytes from COVID-19 patients enrolled in the ImmunoCoV study being carried out by CHUV’s Service of Immunology and Allergy. This antibody is one of the most powerful identified so far against SARS-CoV-2. Structural characterization of the antibody indicates that it binds to an area that is not subjected to mutations of the spike protein. (Source: World Pharma News)
Source: World Pharma News - October 12, 2021 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

FDA Approves First Therapy for Rare Pediatric Immune Disorder FDA Approves First Therapy for Rare Pediatric Immune Disorder
Prior to this approval, patients with congenital athymia, a condition where a child is born without a thymus, only received supportive care.Medscape Medical News (Source: Medscape Transplantation Headlines)
Source: Medscape Transplantation Headlines - October 11, 2021 Category: Transplant Surgery Tags: Allergy & Clinical Immunology News Source Type: news

PhD warns that at least 150,000 Americans have died from covid vaccines (so far)
(Natural News) Based on data collected from the VAERS (Vaccine Adverse Event Reporting System) database, Dr. Jessica Rose, PhD, a computational biologist, molecular biologist and immunologist, has determined that at least 150,000 people in the United States have died from Wuhan coronavirus (Covid-19) “vaccines” as of Aug. 28, 2021. Rose utilized both VAERS data and... (Source: NaturalNews.com)
Source: NaturalNews.com - October 11, 2021 Category: Consumer Health News Source Type: news

Food allergy-related bullying among children and adolescents - Cooke F, Ramos A, Herbert L.
OBJECTIVE: Food allergy (FA) management requires youth to avoid allergens and carry emergency medication which can impact participation in social activities. Previous research indicates that some youth experience FA-related bullying, but many studies are l... (Source: SafetyLit)
Source: SafetyLit - October 11, 2021 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

TREASON: American government officials caught editing Wuhan lab journal
(Natural News) Government officials in the United States have been caught editing Virologica Sinica, a scientific journal affiliated with the infamous Wuhan Institute of Virology (WIV) that has been pumping out propaganda against the true origins of the Wuhan coronavirus (Covid-19). According to reports, officials who work at Tony Fauci’s National Institute of Allergy and... (Source: NaturalNews.com)
Source: NaturalNews.com - October 8, 2021 Category: Consumer Health News Source Type: news

Janssen Submits Application Seeking U.S. FDA Approval of STELARA ® (ustekinumab) for the Treatment of Pediatric Patients With Juvenile Psoriatic Arthritis
HORSHAM, PENNSYLVANIA, October 8, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the submission of a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) seeking expanded approval of STELARA® (ustekinumab) to treat pediatric patients ages 5 years and older with juvenile psoriatic arthritis (jPsA).The filing is supported by extrapolation of data from nine studies across both adult trials in active PsA and adult and pediatric studies in moderate to severe plaque psoriasis, totaling 3,997 patients evaluated across these closely associa...
Source: Johnson and Johnson - October 8, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

No Causal Relationship Seen Between Allergic Disease, Mental Health
Mendelian randomization did not show evidence of causal effects between genetic risk for allergic disease and self - reported mental health (Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - October 7, 2021 Category: Psychiatry Tags: Dermatology, Family Medicine, Internal Medicine, Allergy, Psychiatry, Journal, Source Type: news

New Opdivo/Yervoy Mesothelioma Clinical Trial Begins Soon
A novel clinical trial involving the immunotherapy combination of Opdivo and Yervoy will open soon in Chicago. The goal is to study the drugs’ efficacy when added to surgery for patients with peritoneal mesothelioma cancer. The single-center, phase II clinical trial follows a recent report detailing the impressive three-year effectiveness of the drug combination when used for unresectable pleural mesothelioma. Bristol Myers Squibb manufactures Opdivo and Yervoy, known generically as nivolumab and ipilimumab. The U.S. Food and Drug Administration approved the combination for pleural mesothelioma in 2020, making ...
Source: Asbestos and Mesothelioma News - October 7, 2021 Category: Environmental Health Authors: Fran Mannino Source Type: news

The CDC Turns Its Back on Migrants and Science
Credit: UNOHCR.By Jamile Tellez Lieberman and Joe AmonPHILADELPHIA, US, Oct 7 2021 (IPS) Last month, asylum-seeking families at the U.S.-Mexico border appeared to have won a victory, however temporary, in their last-ditch bid for safety in the United States. It was also a victory for evidence-based public health policy. The 1,954-mile-long southern border has always been a magnet for debate, with deep political divides. Bolstered by Donald Trump during his presidency, long-simmering anti-immigrant rhetoric and xenophobia surrounding migration and immigration increased dramatically. Starting in 2016, under the previous admi...
Source: IPS Inter Press Service - Health - October 7, 2021 Category: International Medicine & Public Health Authors: Jamile Tellez Lieberman and Joe Amon Tags: Headlines Health Human Rights Migration & Refugees North America TerraViva United Nations Source Type: news

Kids With Food Allergies Are Often Targets for Bullies
Title: Kids With Food Allergies Are Often Targets for BulliesCategory: Health NewsCreated: 10/7/2021 12:00:00 AMLast Editorial Review: 10/7/2021 12:00:00 AM (Source: MedicineNet Kids Health General)
Source: MedicineNet Kids Health General - October 7, 2021 Category: Pediatrics Source Type: news

Janssen Announces Novel Mechanism of Action that Shows Promise Against Dengue in Data Published in Nature
BEERSE, BELGIUM, October 6, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen) announced today, in collaboration with the KU Leuven Rega Institute and the KU Leuven Centre for Drug Design and Discovery (CD3), the publication of new preclinical data in the journal Nature showing that an early-stage compound with a novel mechanism of action could potentially treat all serotypes of dengue fever and provide a period of protection against acquiring the dengue virus. Janssen is now moving its dengue program into clinical development. Data from the early-stage study suggest that an antiviral comp...
Source: Johnson and Johnson - October 6, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

People with allergies may be more likely to have mental health disorders, study finds
People with asthma, atopic dermatitis and hay fever may be more likely to suffer from depression, anxiety, bipolar disorder and other mental health disorders, a study published by Clinical and Experimental Allergy found. (Source: Health News - UPI.com)
Source: Health News - UPI.com - October 6, 2021 Category: Consumer Health News Source Type: news